References
- Wang L, Swerdel JN, Weaver J, et al. Incidence rate of hospitalization and mortality in the first year following initial diagnosis of cardiac amyloidosis in the US claims databases. Curr Med Res Opin. 2021;37(8):1275–1281.
- Barge-Caballero G, Vázquez-García R, Barge-Caballero E, et al. Light chain and transthyretin cardiac amyloidosis: clinical characteristics, natural history and prognostic factors. Med Clin (Barc). 2021;156(8):369–378.
- Liu T, Ditzhaus M, Xu J. A resampling-based test for two crossing survival curves. Pharm Stat. 2020;19(4):399–409.
- Kuitunen I, Ponkilainen VT, Uimonen MM, et al. Testing the proportional hazards assumption in Cox regression and dealing with possible non-proportionality in total joint arthroplasty research: methodological perspectives and review. BMC Musculoskelet Disord. 2021;22(1):489.
- Dormuth I, Liu T, Xu J, et al. Which test for crossing survival curves? A user’s guideline. BMC Med Res Methodol. 2022;22(1):34.